Vascular graft infections: In vitro and in vivo investigations of a new vascular graft with long-term protection

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 74, Issue 1, 2005, Pages 601-607

  Ueberrueck, Torsten ^a   Zippel, Roland ^d   Tautenhahn, Joerg ^c   Gastinger, Ingo ^b   Lippert, Hans ^c   Wahlers, Thorsten ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b Carl Thiem Hospital   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

^d Krankenhaus Riesa   (Germany)

Author keywords

Antimicrobial; Sustained release; Vascular graft

Indexed keywords

BACTERIA; IMPREGNATION; INDUCTIVELY COUPLED PLASMA; POLYESTERS; SPECTROMETRY;

ANTIBACTERIAL EFFICACY; ATOMIC EMISSION SPECTROMETRY; POLYESTER VASCULAR PROSTHESIS (PET); VASCULAR GRAFT INFECTIONS;

PROSTHETICS;

AGAR; GELATIN; POLYESTER; SILVER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ARTICLE; ATOMIC EMISSION SPECTROMETRY; BACTERIAL GROWTH; BACTERIUM CONTAMINATION; BACTERIUM CULTURE; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; COLONY FORMING UNIT; CONTROLLED STUDY; ESCHERICHIA COLI; GRAFT INFECTION; IN VITRO STUDY; IN VIVO STUDY; MATERIAL COATING; NONHUMAN; RABBIT; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; SUSPENSION;

ANIMALS; ANTI-BACTERIAL AGENTS; BACTERIA; BIOPROSTHESIS; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; ESCHERICHIA COLI; GELATIN; POLYESTERS; PROSTHESIS-RELATED INFECTIONS; RABBITS; SILVER; SPECTROPHOTOMETRY, ATOMIC; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; STEM CELLS; SURGICAL WOUND INFECTION; TIME FACTORS;

EID: 21444444890     PISSN: 00219304     EISSN: None     Source Type: Journal    
DOI: 10.1002/jbm.b.30265     Document Type: Article

References (46)

1. Benvenisty AI, Tannenbaum G, Ahlborn TN, Fox CL, Modak S, Sampath L, Reemtsma K, Nowygrod R. Control of prosthetic bacterial infection: evaluation of an easily incorporated, tightly bound, silver antibiotic PTFE graft. J Surg Res 1988;44:1-7.
2. Coggia M, Goeau-Brissonniere O, Leflon V, Nicolas MH, Pechere JC. Experimental treatment of vascular graft infection due to Staphylococcus epidermidis by in situ replacement with a rifampin-bonded polyester graft. Ann Vasc Surg 2001;15: 421-429.
3. Goeau-Brissonniere O, Leflon V, Letort M, Nicolas MH. Resistance of antibiotic-bonded gelatin-coated polymer meshes to Staphylococcus aureus in a rabbit subcutaneous pouch model. Biomaterials 1999;20:229-232.
4. Kinney EV, Bandyk DF, Seabrook GA, Kelly HM, Towne JB. Antibiotic-bonded PTFE vascular grafts: the effect of silver antibiotic on bioactivity following implantation. J Surg Res 1991;50:430-435.
5. Modak SM, Sampath L, Fox CL Jr, Benvenisty A, Nowygrod R, Reemstmau K. A new method for the direct incorporation of antibiotic in prosthetic vascular grafts. Surg Gynecol Obstet 1987;164:143-147.
6. Muller G, Winkler Y, Kramer A. Antibacterial activity and endotoxin-binding capacity of Actisorb Silver 220. J Hosp Infect 2003;53:211-214.
7. Riley DK, Classen DC, Stevens LE, Burke JP. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med 1995; 98:349-356.
8. Yoshida K, Tanagawa M, Matsumoto S, Yamada T, Atsuta M. Antibacterial activity of resin composites with silver-containing materials. Eur J Oral Sci 1999;107:290-296.
9. Darouiche RO. Anti-infective efficacy of silver-coated medical prostheses. Clin Infect Dis 1999;29:1371-1377.
10. Goeau-Brissonniere OA, Fabre D, Leflon-Guibout V, Di C, 1, Nicolas-Chanoine MH, Coggia M. Comparison of the resistance to infection of rifampin-bonded gelatin-sealed and silver/collagen-coated polyester prostheses. J Vasc Surg 2002;35:1260-1263.
11. Hernandez-Richter T, Schardey HM, Wittmann F, Mayr S, Schmitt-Sody M, Blasenbreu S, Heiss MM, Gabka C, Angele MK. Rifampin and Triclosan but not silver is effective in preventing bacterial infection of vascular dacron graft material. Eur J Vasc Endovasc Surg 2003;26:550-557.
12. Liau SY, Read DC, Pugh WJ, Furr JR, Russell AD. Interaction of silver nitrate with readily identifiable groups: relationship to the antibacterial action of silver ions. Lett Appl Microbiol 1997;25:279-283.
13. Bernex F, Mazzucotelli JP, Roudiere JL, Benhaiem-Sigaux N, Leandri J, Loisance D. In vitro endothelialization of carbon-coated Dacron vascular grafts. Int J Artif Organs 1992;15:172-180.
14. Grossner-Schreiber B, Griepentrog M, Haustein I, Muller WD, Lange KP, Briedigkeit H, Gobel UB. Plaque formation on surface modified dental implants. An in vitro study. Clin Oral Implants Res 2001;12:543-551.
15. Ward LP, Subramanian C, Strafford KN, Wilks TP. Sliding wear studies of selected nitride coatings and their potential for long-term use in orthopaedic applications. Proc Inst Mech Eng [H] 1998;212:303-315.
16. Lovering AM, White LO, MacGowan AP, Reeves DS. The elution and binding characteristics of rifampicin for three commercially available protein-sealed vascular grafts. J Antimicrob Chemother 1996;38:599-604.
17. Wachol-Drewek Z, Pfeiffer M, Scholl E. Comparative investigation of drug delivery of collagen implants saturated in anti-biotic solutions and a sponge containing gentamicin. Biomaterials 1996;17:1733-1738.
18. Liao SS, Cui FZ. In vitro and in vivo degradation of mineralized collagen-based composite scaffold: nanohydroxyapatite/collagen/poly(L-lactide). Tissue Eng 2004;10:73-80.
19. Tsolakidou A, Kilikoglou V. Comparative analysis of ancient ceramics by neutron activation analysis, inductively coupled plasma-optical-emission spectrometry, inductively coupled plasma-mass spectrometry, and X-ray fluorescence. Anal Bioanal Chem 2002;374:566-572.
20. Wustkamp D, Kucharkowski R, Broekaert JA. Improved accuracy for the analysis of soft magnetic alloys by inductively-coupled plasma atomic emission spectrometry by using advanced standardization procedures. Anal Bioanal Chem 1996; 354:879-882.
21. Feng QL, Wu J, Chen GQ, Cui FZ, Kim TN, Kim JO. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res 2000;52:662-668.
22. Joyce-Wohrmann RM, Munstedt H. Determination of the silver ion release from polyurethanes enriched with silver. Infection 1999;27(suppl 1):S46-S48.
23. Kawai K, Suzuki S, Tabata Y, Taira T, Ikada Y, Nishimura Y. Development of an artificial dermis preparation capable of silver sulfadiazine release. J Biomed Mater Res 2001;57:346-356.
24. Lansdown AB, Silver. I. Its antibacterial properties and mechanism of action. J Wound Care 2002;11:125-130.
25. Mi FL, Wu YB, Shyu SS, Schoung JY, Huang YB, Tsai YH, Hao JY. Control of wound infections using a bilayer chitosan wound dressing with sustainable antibiotic delivery. J Biomed Mater Res 2002;59:438-449.
26. Bellantone M, Williams HD, Hench LL. Broad-spectrum bactericidal activity of Ag(2)O-doped bioactive glass. Antimicrob Agents Chemother 2002;46:1940-1945.
27. Kawahara K, Tsuruda K, Morishita M, Uchida M. Antibacterial effect of silver-zeolite on oral bacteria under anaerobic conditions. Dent Mater 2000;16:452-455.
28. Kawashita M, Tsuneyama S, Miyaji F, Kokubo T, Kozuka H, Yamamoto K. Antibacterial silver-containing silica glass prepared by sol-gel method. Biomaterials 2000;21:393-398.
29. Reiche T, Lisby G, Jorgensen S, Christensen AB, Nordling J. A prospective, controlled, randomized study of the effect of a slow-release silver device on the frequency of urinary tract infection in newly catheterized patients. BJU Int 2000;85:54-59.
30. Bach A, Schmidt H, Bottiger B, Schreiber B, Bohrer H, Motsch J, Martin E, Sonntag HG. Retention of antibacterial activity and bacterial colonization of antiseptic-bonded central venous catheters. J Antimicrob Chemother 1996;37:315-322.
31. Gray JE, Norton PR, Alnouno R, Marolda CL, Valvano MA, Griffiths K. Biological efficacy of electroless-deposited silver on plasma activated polyurethane. Biomaterials 2003;24:2759-2765.
32. Yorganci K, Krepel C, Weigelt JA, Edmiston CE. In vitro evaluation of the antibacterial activity of three different central venous catheters against gram-positive bacteria. Eur J Clin Microbiol Infect Dis 2002;21:379-384.
33. Shah PM, Modak S, Fox CL, Babu SC, Sampath L, Clauss RH, Stahl WM. PTFE graft treated with silver norfloxacin (AgNF): drug retention and resistance to bacterial challenge. J Surg Res 1987;42:298-303.
34. Russell AD, Hugo WB. Antimicrobial activity and action of silver. Prog Med Chem 1994;31:351-370.
35. Slawson RM, Lee H, Trevors JT. Bacterial interactions with silver. Biol Met 1990;3:151-154.
36. Wright JB, Lam K, Hansen D, Burrell RE. Efficacy of topical silver against fungal burn wound pathogens. Am J Infect Control 1999;27:344-350.
37. Zhao G, Stevens SE Jr. Multiple parameters for the comprehensive evaluation of the susceptibility of Escherichia coli to the silver ion. Biometals 1998;11:27-32.
38. EC Scientific Committee on Medical Products and Medical Devices. Evaluation of certain food additives and contaminants. World Health Organ Tech Rep Ser 2001;901:i-107.
39. Guggenbichler JP, Boswald M, Lugauer S, Krall T. A new technology of microdispersed silver in polyurethane induces antimicrobial activity in central venous catheters. Infection 1999;27(suppl 1):S16-S23.
40. Strathmann M, Wingender J. Use of an oxonal dye in combination with confocal laser scanning microscopy to monitor damage of Staphylococcus aureus cells during colonization of silver-coated vascular grafts, Int J Antimicrob Agents 2004;24: 234-240.
41. Hernandez-Richter T, Schardey HM, Lohlein F, Heiss MM, Redondo-Muller M, Hammer C, Schildberg FW. The prevention and treatment of vascular graft infection with a Triclosan (Irgasan)-bonded Dacron graft: an experimental study in the pig. Eur J Vasc Endovasc Surg 2000;20:413-418.
42. Batt M, Magne JL, Alric P, Muzj A, Ruotolo C, Ljungstrom KG, Garcia-Casas R, Simms M. In situ revascularization with silver-coated polyester grafts to treat aortic infection: early and midterm results. J Vasc Surg 2003;38:983-989.
43. Hayes PD, Nasim A, London NJ, Sayers RD, Barrie WW, Bell PR, Naylor AR. In situ replacement of infected aortic grafts with rifampicin-bonded prostheses: the Leicester experience (1992 to 1998). J Vasc Surg 1999;30:92-98.
44. Jones L, Braithwaite BD, Davies B, Heather BP, Earnshaw JJ. Mechanism of late prosthetic vascular graft infection. Cardiovasc Surg 1997;5:486-489.
45. Ueberrueck T, Meyer L, Zippel R, Nestler G, Wahlers T, Gastinger I. Healing characteristics of a new silver coated, gelatine impregnated vascular prosthesis in the porcine model. Zentralbl Chir 2005;130:71-76.
46. Bodnar E. The Silzone dilemma-what did we learn? J Heart Valve Dis 2000;9:170-173.